-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi takes 26.4% stake in Cheplapharm in mature drugs partnership

PUBT·09/14/2026 15:15:03
Listen to the news
Sanofi takes 26.4% stake in Cheplapharm in mature drugs partnership
  • Sanofi will take a 26.4% equity stake in Cheplapharm under a proposed strategic partnership for mature medicines.
  • Cheplapharm would acquire a portfolio of 20 mature drugs from Sanofi, with Lovenox/Clexane included outside the U.S.
  • Three manufacturing sites would transfer to Cheplapharm in Hungary, Singapore, France, with commercial transfer targeted for Q1 2027.
  • Transaction expected to close in Q3 2027, subject to employee consultations, regulatory approvals, closing conditions.
  • No impact expected on Sanofi’s 2026 financial guidance; additional financial terms to be disclosed later.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief on September 14, 2026, and is solely responsible for the information contained therein.